S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Laser breakthrough could send stock soaring 2,467% (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and GOP rush to complete debt ceiling deal, shore up support to prevent default
3 Free Stock Picks per Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
3 Free Stock Picks per Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Laser breakthrough could send stock soaring 2,467% (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and GOP rush to complete debt ceiling deal, shore up support to prevent default
3 Free Stock Picks per Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
3 Free Stock Picks per Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Laser breakthrough could send stock soaring 2,467% (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and GOP rush to complete debt ceiling deal, shore up support to prevent default
3 Free Stock Picks per Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
3 Free Stock Picks per Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
Laser breakthrough could send stock soaring 2,467% (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden and GOP rush to complete debt ceiling deal, shore up support to prevent default
3 Free Stock Picks per Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
3 Free Stock Picks per Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
LON:HVO

hVIVO (HVO) Share Forecast, Price & News

GBX 16.38
-0.22 (-1.33%)
(As of 05/26/2023 04:34 PM ET)
Compare
Today's Range
16.25
17
50-Day Range
14.15
19
52-Week Range
9.20
23.40
Volume
690,198 shs
Average Volume
2.27 million shs
Market Capitalization
£109.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HVO stock logo

About hVIVO (LON:HVO) Stock

hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services.

hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.

Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Stock News Headlines

NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
hVIVO plc (HVO) to Issue Dividend of GBX 0.45 on June 9th
hVIVO plc (HVO.L)
NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
3 no-brainer UK shares to buy in February
We Might See A Profit From hVIVO plc (LON:HVO) Soon
Hvivo Plc Share Price (HVO.GB.PL)
1 penny stock I’m buying right now!
Is hVIVO plc (LON:HVO) Potentially Undervalued?
1 penny stock under 13p I’d snap up right now
Open Orphan Share Chat
Hvivo Plc Share Chat
Hvivo Share News (HVO)
HVIVO PLC
Can hVIVO (LON:HVO) Afford To Invest In Growth?
See More Headlines
Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Company Calendar

Last Earnings
4/19/2018
Ex-Dividend for 6/9 Dividend
5/04/2023
Today
5/28/2023
Dividend Payable
6/09/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-1,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£50.70 million
Cash Flow
GBX 3.32 per share
Book Value
GBX 3 per share

Miscellaneous

Free Float
N/A
Market Cap
£109.92 million
Optionable
Not Optionable
Beta
1.10

Key Executives

  • Dr. Yamin Mohammed Khan Ph.D. (Age 54)
    CEO & Director
  • Mr. Stephen Pinkerton
    CFO & Exec. Director
  • Mr. Andrew Catchpole
    Chief Scientific Officer
  • Dr. Maurice N. Treacy Ph.D.
    Chief Commercial Officer
  • Ms. Teja Marathe-Sarvadikar
    Head of QA













HVO Stock - Frequently Asked Questions

How have HVO shares performed in 2023?

hVIVO's stock was trading at GBX 10 on January 1st, 2023. Since then, HVO stock has increased by 63.8% and is now trading at GBX 16.38.
View the best growth stocks for 2023 here
.

How were hVIVO's earnings last quarter?

hVIVO plc (LON:HVO) posted its earnings results on Thursday, April, 19th. The company reported ($16.50) earnings per share for the quarter, missing analysts' consensus estimates of ($10.90) by $5.60. hVIVO had a negative trailing twelve-month return on equity of 3.80% and a negative net margin of 1.53%.

How often does hVIVO pay dividends? What is the dividend yield for hVIVO?

hVIVO announced a dividend on Tuesday, April 25th. Shareholders of record on Thursday, May 4th will be paid a dividend of GBX 0.45 per share on Friday, June 9th. This represents a dividend yield of 2.65%. The ex-dividend date is Thursday, May 4th. The official announcement can be viewed at this link.
Read our dividend analysis for HVO
.

What other stocks do shareholders of hVIVO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY).

What is hVIVO's stock symbol?

hVIVO trades on the London Stock Exchange (LON) under the ticker symbol "HVO."

How do I buy shares of hVIVO?

Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is hVIVO's stock price today?

One share of HVO stock can currently be purchased for approximately GBX 16.38.

How much money does hVIVO make?

hVIVO (LON:HVO) has a market capitalization of £109.92 million and generates £50.70 million in revenue each year.

How can I contact hVIVO?

hVIVO's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The official website for the company is hvivo.com. The company can be reached via phone at +44-20-77561300.

This page (LON:HVO) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -